Cargando…

(+)-[(18)F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls

PURPOSES: We present the first in-human brain PET imaging data of the new α4β2 nicotinic acetylcholine receptor (nAChR)–targeting radioligand (+)-[(18)F]Flubatine. Aims were to develop a kinetic modeling-based approach to quantify (+)-[(18)F]Flubatine and compare the data of healthy controls (HCs) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tiepolt, Solveig, Becker, Georg-Alexander, Wilke, Stephan, Cecchin, Diego, Rullmann, Michael, Meyer, Philipp M., Barthel, Henryk, Hesse, Swen, Patt, Marianne, Luthardt, Julia, Wagenknecht, Gudrun, Sattler, Bernhard, Deuther-Conrad, Winnie, Ludwig, Friedrich-Alexander, Fischer, Steffen, Gertz, Hermann-Josef, Smits, René, Hoepping, Alexander, Steinbach, Jörg, Brust, Peter, Sabri, Osama
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036219/ https://www.ncbi.nlm.nih.gov/pubmed/32935187 http://dx.doi.org/10.1007/s00259-020-05029-w

Ejemplares similares

Radiation dosimetry of the α(4)β(2) nicotinic receptor ligand (+)-[(18)F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results
por: Kranz, Mathias, et al.
Publicado: (2016)

Exploring the Metabolism of (+)-[(18)F]Flubatine In Vitro and In Vivo: LC-MS/MS Aided Identification of Radiometabolites in a Clinical PET Study †
por: Ludwig, Friedrich-Alexander, et al.
Publicado: (2018)

Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer’s dementia
por: Sabri, Osama, et al.
Publicado: (2018)

LC-MS Supported Studies on the in Vitro Metabolism of both Enantiomers of Flubatine and the in Vivo Metabolism of (+)-[(18)F]Flubatine—A Positron Emission Tomography Radioligand for Imaging α4β2 Nicotinic Acetylcholine Receptors
por: Ludwig, Friedrich-Alexander, et al.
Publicado: (2016)

Feasibility of in vivo (18)F-florbetaben PET/MR imaging of human carotid amyloid-β
por: Bucerius, Jan, et al.
Publicado: (2017)

Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension
por: Frille, Armin, et al.
Publicado: (2020)

In vitro and in vivo Human Metabolism of (S)-[(18)F]Fluspidine – A Radioligand for Imaging σ(1) Receptors With Positron Emission Tomography (PET)
por: Ludwig, Friedrich-Alexander, et al.
Publicado: (2019)

Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[(11)C]methylreboxetine positron emission tomography study
por: Ulke, Christine, et al.
Publicado: (2019)

Impact of attenuation correction on clinical [(18)F]FDG brain PET in combined PET/MRI
por: Werner, P., et al.
Publicado: (2016)

Current radiotracers to image neurodegenerative diseases
por: Tiepolt, Solveig, et al.
Publicado: (2019)

Multicenter (18)F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer’s Disease
por: Rullmann, Michael, et al.
Publicado: (2022)

Availability of Central α4β2* Nicotinic Acetylcholine Receptors in Human Obesity
por: Schweickert de Palma, Eva, et al.
Publicado: (2022)

Higher HbA1c levels associate with lower hippocampal serotonin transporter availability in non-diabetic adults with obesity
por: Grundmann, Rico, et al.
Publicado: (2020)

Dissociation of amyloid biomarkers in PET and CSF in Alzheimer’s disease: a case report
por: Schroeter, Matthias L., et al.
Publicado: (2015)

Evaluation of the Enantiomer Specific Biokinetics and Radiation Doses of [(18)F]Fluspidine—A New Tracer in Clinical Translation for Imaging of σ(1) Receptors
por: Kranz, Mathias, et al.
Publicado: (2016)

Suppressed Fat Appetite after Roux-en-Y Gastric Bypass Surgery Associates with Reduced Brain μ-opioid Receptor Availability in Diet-Induced Obese Male Rats
por: Hankir, Mohammed K., et al.
Publicado: (2017)

Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [(18)F] fluspidine and [(18)F] fallypride PET study
por: Grachev, Igor D., et al.
Publicado: (2020)

HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls
por: Schinke, Christian, et al.
Publicado: (2022)

Preclinical Incorporation Dosimetry of [(18)F]FACH—A Novel (18)F-Labeled MCT1/MCT4 Lactate Transporter Inhibitor for Imaging Cancer Metabolism with PET
por: Sattler, Bernhard, et al.
Publicado: (2020)

Preclinical Evaluation of [(18)F]FACH in Healthy Mice and Piglets: An (18)F-Labeled Ligand for Imaging of Monocarboxylate Transporters with PET
por: Gündel, Daniel, et al.
Publicado: (2021)

Fully automated calculation of image-derived input function in simultaneous PET/MRI in a sheep model
por: Jochimsen, Thies H., et al.
Publicado: (2016)

Association between Individual Norepinephrine Transporter (NET) Availability and Response to Pharmacological Therapy in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Huang, Jue, et al.
Publicado: (2022)

Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients
por: Schmidt, Elisa, et al.
Publicado: (2020)

A realistic phantom of the human head for PET-MRI
por: Harries, Johanna, et al.
Publicado: (2020)

A Promising PET Tracer for Imaging of α(7) Nicotinic Acetylcholine Receptors in the Brain: Design, Synthesis, and in Vivo Evaluation of a Dibenzothiophene-Based Radioligand
por: Teodoro, Rodrigo, et al.
Publicado: (2015)

A comparison of advanced semi-quantitative amyloid PET analysis methods
por: Peira, Enrico, et al.
Publicado: (2022)

Central Noradrenergic Neurotransmission and Weight Loss 6 Months After Gastric Bypass Surgery in Patients with Severe Obesity
por: Soeder, J. Marvin, et al.
Publicado: (2021)

Improved in vivo PET imaging of the adenosine A(2A) receptor in the brain using [(18)F]FLUDA, a deuterated radiotracer with high metabolic stability
por: Lai, Thu Hang, et al.
Publicado: (2021)

Development of (18)F-Labeled Radiotracers for PET Imaging of the Adenosine A(2A) Receptor: Synthesis, Radiolabeling and Preliminary Biological Evaluation
por: Lai, Thu Hang, et al.
Publicado: (2021)

Ethnic comparison of pharmacokinetics of (18)F-florbetaben, a PET tracer for beta-amyloid imaging, in healthy Caucasian and Japanese subjects
por: Senda, Michio, et al.
Publicado: (2014)

PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner
por: Hirsch, Franz Wolfgang, et al.
Publicado: (2013)

A novel thermoregulatory role for PDE10A in mouse and human adipocytes
por: Hankir, Mohammed K, et al.
Publicado: (2016)

Development of cannabinoid receptor (CB 2 R) ligands for application in PET studies - where to attach the radiolabel?
por: Günther, Robert, et al.
Publicado: (2014)

Comparison of volumetric and functional parameters in simultaneous cardiac PET/MR: feasibility of volumetric assessment with residual activity from prior PET/CT
por: Lücke, C., et al.
Publicado: (2017)

Radiofluorination and biological evaluation of N-aryl-oxadiazolyl-propionamides as potential radioligands for PET imaging of cannabinoid CB(2) receptors
por: Teodoro, Rodrigo, et al.
Publicado: (2013)

Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity
por: Griebsch, Nora-Isabell, et al.
Publicado: (2022)

Development of a New Radiofluorinated Quinoline Analog for PET Imaging of Phosphodiesterase 5 (PDE5) in Brain
por: Liu, Jianrong, et al.
Publicado: (2016)

Development of [(18)F]LU14 for PET Imaging of Cannabinoid Receptor Type 2 in the Brain
por: Teodoro, Rodrigo, et al.
Publicado: (2021)

Development of a Radiofluorinated Adenosine A(2B) Receptor Antagonist as Potential Ligand for PET Imaging
por: Lindemann, Marcel, et al.
Publicado: (2020)

Aβ-Targeting Bifunctional Chelators (BFCs) for Potential Therapeutic and PET Imaging Applications
por: Krasnovskaya, Olga, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nkerop2lrhdh5m11r3qds51s8p